{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:38:12Z","timestamp":1771918692435,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"crossref","award":["FIS\/IMSS\/PROT\/G17\/1663"],"award-info":[{"award-number":["FIS\/IMSS\/PROT\/G17\/1663"]}],"id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10067-019-04805-w","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T07:03:11Z","timestamp":1573542191000},"page":"463-469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Helicobacter pylori infection and gastroduodenal lesions in patients with systemic lupus erythematosus"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1696-9871","authenticated-orcid":false,"given":"Claudia","family":"Mendoza-Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5101-7705","authenticated-orcid":false,"given":"Mario","family":"Garc\u00eda-Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Socorro","family":"M\u00e9ndez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Mogoll\u00e1n-Delf\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Mungu\u00eda-Realpozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efr\u00e9n","family":"Herrera-Robles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivet","family":"Etchegaray-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"G\u00e1lvez-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0531-9611","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Montiel-Jarqu\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"L\u00f3pez-Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"4805_CR1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5694\/j.1326-5377.1985.tb113443.x","volume":"142","author":"BJ Marshall","year":"1985","unstructured":"Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ (1985) Attempt to fulfil Koch\u2019s postulates for pyloric Campylobacter. Med J Aust 142:436\u2013439","journal-title":"Med J Aust"},{"key":"4805_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0140-6736(97)04523-6","volume":"350","author":"FK Chan","year":"1997","unstructured":"Chan FK, Sung JJ, Chung SC et al (1997) Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet (London, England) 350:975\u2013979","journal-title":"Lancet (London, England)"},{"key":"4805_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0016-5085(99)70120-4","volume":"116","author":"AS Taha","year":"1999","unstructured":"Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, Sturrock RD, Russell RI (1999) Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers. Gastroenterology 116:254\u2013258","journal-title":"Gastroenterology"},{"key":"4805_CR4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/00365529850171459","volume":"33","author":"M Voutilainen","year":"1998","unstructured":"Voutilainen M, Sokka T, Juhola M, Farkkil\u00e4 M, Hannonen P (1998) Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer. Scand J Gastroenterol 33:811\u2013816","journal-title":"Scand J Gastroenterol"},{"key":"4805_CR5","doi-asserted-by":"publisher","first-page":"7340","DOI":"10.3748\/wjg.v11.i46.7340","volume":"11","author":"L Veijola","year":"2005","unstructured":"Veijola L, Myllyluoma E, Korpela R, Rautelin H (2005) Stool antigen tests in the diagnosis of Helicobacter pylori infection before and after eradication therapy. World J Gastroenterol 11:7340\u20137344","journal-title":"World J Gastroenterol"},{"key":"4805_CR6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jcp.56.10.769","volume":"56","author":"J Andrews","year":"2003","unstructured":"Andrews J, Marsden B, Brown D, Wong VS, Wood E, Kelsey M (2003) Comparison of three stool antigen tests for Helicobacter pylori detection. J Clin Pathol 56:769\u2013771","journal-title":"J Clin Pathol"},{"key":"4805_CR7","first-page":"557","volume":"16","author":"DJ Wallace","year":"1989","unstructured":"Wallace DJ, Metzger AL, Klinenberg JR (1989) NSAID usage patterns by rheumatologists in the treatment of SLE. J Rheumatol 16:557\u2013560","journal-title":"J Rheumatol"},{"key":"4805_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00005792-199905000-00003","volume":"78","author":"R Cervera","year":"1999","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Aydintug AO, Jedryka-G\u00f3ral A, de Ram\u00f3n E, Fern\u00e1ndez-Nebro A, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ruiz-Irastorza G, Ingelmo M, Hughes GR (1999) Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 78:167\u2013175","journal-title":"Medicine (Baltimore)"},{"key":"4805_CR9","doi-asserted-by":"publisher","first-page":"9698086","DOI":"10.1155\/2019\/9698086","volume":"2019","author":"TM Reshetnyak","year":"2019","unstructured":"Reshetnyak TM, Doroshkevich IA, Seredavkina NV, Nasonov EL, Maev IV, Reshetnyak VI (2019) The contribution of drugs and Helicobacter pylori to gastric mucosa changes in patients with systemic lupus erythematosus and antiphospholipid syndrome. Int J Rheumatol 2019:9698086. https:\/\/doi.org\/10.1155\/2019\/9698086","journal-title":"Int J Rheumatol"},{"key":"4805_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1365-2125.2009.03445.x","volume":"68","author":"J-C Luo","year":"2009","unstructured":"Luo J-C, Chang F-Y, Chen T-S, Ng YY, Lin HC, Lu CL, Chen CY, Lin HY, Lee SD (2009) Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy. Br J Clin Pharmacol 68:252\u2013259. https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03445.x","journal-title":"Br J Clin Pharmacol"},{"key":"4805_CR11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane D, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277","journal-title":"Arthritis Rheum"},{"key":"4805_CR12","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"key":"4805_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","volume":"130","author":"DA Drossman","year":"2006","unstructured":"Drossman DA (2006) The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130:1377\u20131390. https:\/\/doi.org\/10.1053\/j.gastro.2006.03.008","journal-title":"Gastroenterology"},{"key":"4805_CR14","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288\u2013291","journal-title":"J Rheumatol"},{"key":"4805_CR15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/art.1780390303","volume":"39","author":"D Gladman","year":"1996","unstructured":"Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Kalunian K, Maddison P, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D, Zoma A (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363\u2013369","journal-title":"Arthritis Rheum"},{"key":"4805_CR16","first-page":"1097","volume":"16","author":"S Kazemi","year":"2011","unstructured":"Kazemi S, Tavakkoli H, Habizadeh MR, Emami MH (2011) Diagnostic values of Helicobacter pylori diagnostic tests: stool antigen test, urea breath test, rapid urease test, serology and histology. J Res Med Sci 16:1097\u20131104","journal-title":"J Res Med Sci"},{"key":"4805_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"MF Dixon","year":"1996","unstructured":"Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161\u20131181","journal-title":"Am J Surg Pathol"},{"key":"4805_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3978\/j.issn.2305-5839.2014.11.03","volume":"3","author":"JY Lee","year":"2015","unstructured":"Lee JY, Kim N (2015) Diagnosis of Helicobacter pylori by invasive test: histology. Ann Transl Med 3:10. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.11.03","journal-title":"Ann Transl Med"},{"key":"4805_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00004836-199707000-00024","volume":"25","author":"Y Watanabe","year":"1997","unstructured":"Watanabe Y, Ozasa K, Higashi A et al (1997) Helicobacter pylori infection and atrophic gastritis. A case-control study in a rural town of Japan. J Clin Gastroenterol 25:391\u2013394","journal-title":"J Clin Gastroenterol"},{"key":"4805_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/515663","volume":"178","author":"J Torres","year":"1998","unstructured":"Torres J, Leal-Herrera Y, Perez-Perez G, Gomez A, Camorlinga-Ponce M, Cedillo-Rivera R, Tapia-Conyer R, Mu\u00f1oz O (1998) A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis 178:1089\u20131094","journal-title":"J Infect Dis"},{"key":"4805_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1046\/j.1523-5378.2002.00092.x","volume":"7","author":"L Kalabay","year":"2002","unstructured":"Kalabay L, Fekete B, Czirjak L et al (2002) Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 7:250\u2013256","journal-title":"Helicobacter"},{"key":"4805_CR22","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1348-0421.1996.tb01100.x","volume":"40","author":"Y Showji","year":"1996","unstructured":"Showji Y, Nozawa R, Sato K, Suzuki H (1996) Seroprevalence of Helicobacter pylori infection in patients with connective tissue diseases. Microbiol Immunol 40:499\u2013503","journal-title":"Microbiol Immunol"},{"key":"4805_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1083-4389.2004.00206.x","volume":"9","author":"MC Camargo","year":"2004","unstructured":"Camargo MC, Lazcano-Ponce E, Torres J, Velasco-Mondragon E, Quiterio M, Correa P (2004) Determinants of Helicobacter pylori seroprevalence in Mexican adolescents. Helicobacter 9:106\u2013114. https:\/\/doi.org\/10.1111\/j.1083-4389.2004.00206.x","journal-title":"Helicobacter"},{"key":"4805_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1053\/gast.1996.v110.pm8608881","volume":"110","author":"J Labenz","year":"1996","unstructured":"Labenz J, Tillenburg B, Peitz U et al (1996) Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 110:725\u2013732","journal-title":"Gastroenterology"},{"key":"4805_CR25","first-page":"1195","volume":"28","author":"B Seriolo","year":"2001","unstructured":"Seriolo B, Cutolo M, Zentilin P, Savarino V (2001) Helicobacter pylori infection in rheumatoid arthritis. J Rheumatol 28:1195\u20131196","journal-title":"J Rheumatol"},{"key":"4805_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/rheumatology\/41.1.72","volume":"41","author":"N Ishikawa","year":"2002","unstructured":"Ishikawa N, Fuchigami T, Matsumoto T, Kobayashi H, Sakai Y, Tabata H, Takubo N, Yamamoto S, Nakanishi M, Tomioka K, Fujishima M (2002) Helicobacter pylori infection in rheumatoid arthritis: effect of drugs on prevalence and correlation with gastroduodenal lesions. Rheumatology (Oxford) 41:72\u201377","journal-title":"Rheumatology (Oxford)"},{"key":"4805_CR27","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/lary.20258","volume":"119","author":"H Iwai","year":"2009","unstructured":"Iwai H, Nakamichi N, Nakae K, Konishi M, Inaba M, Hoshino S, Baba S, Amakawa R (2009) Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication. Laryngoscope 119:1491\u20131494. https:\/\/doi.org\/10.1002\/lary.20258","journal-title":"Laryngoscope"},{"key":"4805_CR28","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s00296-012-2585-z","volume":"33","author":"M Radic","year":"2013","unstructured":"Radic M, Kaliterna DM, Bonacin D et al (2013) Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis? Rheumatol Int 33:2943\u20132948. https:\/\/doi.org\/10.1007\/s00296-012-2585-z","journal-title":"Rheumatol Int"},{"key":"4805_CR29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(05)60004-9","volume":"352","author":"A Gasbarrini","year":"1998","unstructured":"Gasbarrini A, Franceschi F, Tartaglione R et al (1998) Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (London, England) 352:878. https:\/\/doi.org\/10.1016\/S0140-6736(05)60004-9","journal-title":"Lancet (London, England)"},{"key":"4805_CR30","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/LGT.0b013e31825d2d7a","volume":"16","author":"S Tatti","year":"2012","unstructured":"Tatti S, Suzuki V, Fleider L, Maldonado V, Caruso R, Tinnirello Mde L (2012) Anal intraepithelial lesions in women with human papillomavirus-related disease. J Low Genit Tract Dis 16:454\u2013459. https:\/\/doi.org\/10.1097\/LGT.0b013e31825d2d7a","journal-title":"J Low Genit Tract Dis"},{"issue":"Suppl 1","key":"4805_CR31","first-page":"S109","volume":"6","author":"Y Mizokami","year":"1994","unstructured":"Mizokami Y, Tamura K, Fukuda Y et al (1994) Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori. Eur J Gastroenterol Hepatol 6(Suppl 1):S109\u2013S112","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4805_CR32","first-page":"1732","volume":"87","author":"AS Taha","year":"1992","unstructured":"Taha AS, Sturrock RD, Russell RI (1992) Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 87:1732\u20131735","journal-title":"Am J Gastroenterol"},{"key":"4805_CR33","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1136\/gut.35.10.1385","volume":"35","author":"E El-Omar","year":"1994","unstructured":"El-Omar E, Penman I, Cruikshank G et al (1994) Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut 35:1385\u20131388","journal-title":"Gut"},{"key":"4805_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/00365520310008089","volume":"39","author":"T Moriyama","year":"2004","unstructured":"Moriyama T, Matsumoto T, Fuchigami T et al (2004) Changes in Helicobacter pylori status in patients with rheumatoid arthritis under non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 39:111\u2013118","journal-title":"Scand J Gastroenterol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04805-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04805-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04805-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:57:18Z","timestamp":1605056238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04805-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4805"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04805-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"7 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Mendoza Pinto is currently receiving a grant (FIS\/IMSS\/PROT\/G17\/1663) from FIS\/IMSS. Dr L\u00f3pez-Colombo declares that he acted as a speaker for Takeda, Menarini and Alfa Sigma. The remaining authors report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}}]}}